Kindred Biosciences announces proposed public offering of common stock
Kindred Biosciences announced a proposed public offering of its common stock. All of the common stock is being offered by KindredBio. In addition, KindredBio intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock. January 17, 2019